Calcium Release from Sarcoplasmic Reticulum, Physiol. Rev, vol.57, pp.71-108, 1977. ,
DOI : 10.1016/S0070-2161(08)60768-6
Biochemistry and Biophysics of Excitation-Contraction Coupling, Annual Review of Biophysics and Biophysical Chemistry, vol.18, issue.1, pp.333-364, 1989. ,
DOI : 10.1146/annurev.bb.18.060189.002001
Structure and Development of E-C Coupling Units in Skeletal Muscle, Annual Review of Physiology, vol.56, issue.1, pp.509-534, 1994. ,
DOI : 10.1146/annurev.ph.56.030194.002453
Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions, Physiol. Rev, vol.77, pp.699-729, 1997. ,
Ryanodine Receptor/Ca2+ Release Channels and Their Regulation by Endogenous Effectors, Annual Review of Physiology, vol.56, issue.1, pp.485-508, 1994. ,
DOI : 10.1146/annurev.ph.56.030194.002413
The sarcoplasmic reticulum Ca 2+ channel/ ryanodine receptor: modulation by endogenous effectors, drugs and disease states, Pharmacol. Rev, vol.49, pp.1-51, 1997. ,
Malignant hyperthermia, Science, vol.256, issue.5058, pp.789-794, 1992. ,
DOI : 10.1126/science.1589759
URL : https://hal.archives-ouvertes.fr/inserm-00388722
Malignant Hyperthermia and Central Core Disease: Disorders of Ca2 Release Channels11In collaboration with The American Physiological Society, Thomas E. Andreoli, MD, Editor, The American Journal of Medicine, vol.104, issue.5, pp.470-486, 1998. ,
DOI : 10.1016/S0002-9343(98)00108-9
Ca2+ signalling and muscle disease, European Journal of Biochemistry, vol.93, issue.17, pp.5291-5297, 2000. ,
DOI : 10.1046/j.1432-1327.2000.01566.x
Multi-minicore disease-searching for boundaries: Phenotype analysis of 38 cases, Annals of Neurology, vol.52, issue.5, pp.745-757, 2000. ,
DOI : 10.1002/1531-8249(200011)48:5<745::AID-ANA8>3.0.CO;2-F
80th ENMC International Workshop on Multi-Minicore Disease: 1st International MmD Workshop 12???13th May, 2000, Soestduinen, The Netherlands, Neuromuscular Disorders, vol.12, issue.1, pp.60-68, 2000. ,
DOI : 10.1016/S0960-8966(01)00237-1
Central core disease: clinical features in 13 patients, J. Comp. Pathol, vol.97, pp.597-600, 1987. ,
THE PROGNOSTIC VALUE OF THE MUSCLE BIOPSY IN THE ???FLOPPY INFANT???, Brain, vol.81, issue.4, pp.461-484, 1958. ,
DOI : 10.1093/brain/81.4.461
The spectrum of pathology in central core disease, Neuromuscular Disorders, vol.12, issue.10, pp.930-938, 2002. ,
DOI : 10.1016/S0960-8966(02)00135-9
Common Origin of Rods, Cores, Miniature Cores, and Focal Loss of Cross-Striations, Archives of Neurology, vol.35, issue.9, pp.555-566, 1978. ,
DOI : 10.1001/archneur.1978.00500330003002
Coexistence of minicores, cores, and rods in the same muscle biopsy, Acta Neuropathologica, vol.20, issue.3, pp.229-232, 1982. ,
DOI : 10.1007/BF00690806
A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene, Annals of Neurology, vol.276, issue.11, pp.750-759, 2002. ,
DOI : 10.1002/ana.10231
Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores, Neurology, vol.59, issue.2, pp.284-287, 2002. ,
DOI : 10.1212/WNL.59.2.284
Molecular cloning of cDNA encoding human and rabbit forms of the Ca 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum, J. Biol. Chem, vol.265, pp.2244-2256, 1990. ,
Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor, Nature, vol.339, issue.6224, pp.439-445, 1989. ,
DOI : 10.1038/339439a0
Genetics and pathogenesis of malignant hyperthermia, Muscle & Nerve, vol.49, issue.1, pp.4-17, 2000. ,
DOI : 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D
Ryanodine receptor mutations in malignant hyperthermia and central core disease, Human Mutation, vol.5, issue.5, pp.410-417, 2000. ,
DOI : 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D
Anesthetic deaths in a family, Lancet Lancet, vol.2, issue.352, pp.1131-1136, 1960. ,
Malignant Hyperthermia, JAMA, vol.293, issue.23, pp.2918-2924, 2005. ,
DOI : 10.1001/jama.293.23.2918
Mutations of the Selenoprotein N Gene, Which Is Implicated in Rigid Spine Muscular Dystrophy, Cause the Classical Phenotype of Multiminicore Disease: Reassessing the Nosology of Early-Onset Myopathies, The American Journal of Human Genetics, vol.71, issue.4, pp.739-749, 2002. ,
DOI : 10.1086/342719
release channel, British Journal of Pharmacology, vol.49, issue.Suppl, pp.335-341, 2000. ,
DOI : 10.1038/sj.bjp.0703571
B-lymphocytes from malignant hyperthermia susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators, J. Biol. Chem, vol.276, pp.48077-48082, 2002. ,
A routine method for the establishment of permanent growing lymphoblastoid cell lines, Human Genetics, vol.67, issue.4, pp.320-326, 1986. ,
DOI : 10.1007/BF00279094
Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis, Human Molecular Genetics, vol.10, issue.25, pp.2879-2887, 2001. ,
DOI : 10.1093/hmg/10.25.2879
Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.12, issue.4, pp.379-388, 2003. ,
DOI : 10.1093/hmg/ddg032
Effect of Ryanodine Receptor Mutations on Interleukin-6 Release and Intracellular Calcium Homeostasis in Human Myotubes from Malignant Hyperthermia-susceptible Individuals and Patients Affected by Central Core Disease, Journal of Biological Chemistry, vol.279, issue.42, pp.43838-43446, 2004. ,
DOI : 10.1074/jbc.M403612200
Chlorocresol: an activator of ryanodine receptor-mediated Ca 2+ release, Mol. Pharmacol, vol.44, pp.1192-1201, 1993. ,
Chlorocresol, an Additive to Commercial Succinylcholine, Induces Contracture of Human Malignant Hyperthermia-susceptible Muscles Via Activation of the Ryanodine Receptor Calcium sup 2+ Channel, Anesthesiology, vol.84, issue.6, pp.1380-1385, 1996. ,
DOI : 10.1097/00000542-199606000-00014
4-chloro- m -cresol, a potent and specific activator of the skeletal muscle ryanodine receptor, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1289, issue.1, pp.1-40, 1996. ,
DOI : 10.1016/0304-4165(95)00131-X
Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease, Biochemical and Biophysical Research Communications, vol.322, issue.4, pp.1256-1266, 2004. ,
DOI : 10.1016/j.bbrc.2004.08.031
Multiminicore Myopathy, Central Core Disease, Malignant Hyperthermia Susceptibility, and RYR1 Mutations, Archives of Neurology, vol.61, issue.1, pp.27-28, 2004. ,
DOI : 10.1001/archneur.61.1.27
RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene, Journal of Medical Genetics, vol.41, issue.3, pp.1-7, 2004. ,
DOI : 10.1136/jmg.2003.014274
Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders, Neuromuscular Disorders, vol.15, issue.9-10, pp.57-587, 2005. ,
DOI : 10.1016/j.nmd.2005.06.008
URL : https://hal.archives-ouvertes.fr/hal-00087672
Identification of Apocalmodulin and Ca2+-Calmodulin Regulatory Domain in Skeletal Muscle Ca2+ Release Channel, Ryanodine Receptor, Journal of Biological Chemistry, vol.276, issue.25, pp.22579-22585, 2001. ,
DOI : 10.1074/jbc.M102729200
Interaction of S100A1 with the Ca 2+ release channel (ryanodine receptor) of skeletal muscle, Biochemistry, vol.36, pp.1496-11503, 1997. ,
Modulation of Intracellular Calcium-Release Channels by Calmodulin, Journal of Membrane Biology, vol.185, issue.1, pp.1-8, 2002. ,
DOI : 10.1007/s00232-001-0111-4
Functional properties of EGFP-tagged skeletal muscle calcium-release channel (ryanodine receptor) expressed in COS-7 cells: sensitivity to caffeine and 4-chloro-m-cresol, Cell Calcium, vol.31, issue.1, pp.1-12, 2002. ,
DOI : 10.1054/ceca.2001.0252
Screening of the Entire Ryanodine Receptor Type 1 Coding Region for Sequence Variants Associated with Malignant Hyperthermia Susceptibility in the North American Population, Anesthesiology, vol.102, issue.3, pp.515-521, 2005. ,
DOI : 10.1097/00000542-200503000-00007
Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.10, issue.22, pp.2581-2592, 2001. ,
DOI : 10.1093/hmg/10.22.2581